Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

ABSTRACT: The etiology of prostate cancer, the second most common cancer in men globally, has a strong heritable component. While rare coding germline variants in several genes have been identified as risk factors from candidate gene and linkage studies, the exome-wide spectrum of causal rare variants remains to be fully explored. To more comprehensively address their contribution, we analysed data from 37,184 prostate cancer cases and 331,329 male controls from five cohorts with germline exome/genome sequencing and one cohort with imputed array data from a population enriched in low-frequency deleterious variants. Our gene-level collapsing analysis revealed that rare damaging variants in SAMHD1 as well as genes in the DNA damage response pathway (BRCA2, ATM and CHEK2) ar

SUBMITTER: Mitchell J 

PROVIDER: S-EPMC11100931 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature